Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Medtronic Tells Investors Its ICD Market Share Is Recovering

This article was originally published in The Gray Sheet

  • News

Executive Summary

Medtronic believes its share of the implantable cardioverter defibrillator (ICD) market is stabilizing after withstanding challenges from Boston Scientific and St. Jude

You may also be interested in...



Medtronic Fidelis Fracture Rates Accelerate Over Time, Study Finds

Fracture rates with Medtronic's Sprint Fidelis implantable cardioverter defibrillator leads are increasing over time, according to new research published online Feb. 23 by the journal HeartRhythm

Medtronic Fidelis Fracture Rates Accelerate Over Time, Study Finds

Fracture rates with Medtronic's Sprint Fidelis implantable cardioverter defibrillator leads are increasing over time, according to new research published online Feb. 23 by the journal HeartRhythm

Medtronic InFuse Sales Flat In Q2; Firm’s Spine Business Still Struggling

Medtronic is exploring alternative distribution channels in oral maxillofacial and trauma markets to grow its struggling InFuse bone graft franchise, the firm said during its Nov. 18 fiscal second-quarter earnings call

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application

See All
UsernamePublicRestriction

Register

MT027135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By